Mission Possible

Founding partners Nicolas Berg and Jeroen van den Oever lead the investment committee. Berg oversees deal sourcing for Switzerland, while van den Oever co-leads life-sciences commitments. Partner Adnan Kareem also contributes to life-sciences diligence, and the four-partner group collectively evaluates pre-seed and seed-stage companies sourced through the firm's university network.

The firm converts more than two decades of teaching, judging, and coaching activity at Swiss institutions — including venturelab, Venture Kick, and Startup Campus — into an early look at technical teams before they incorporate. Partners meet founders inside ETH Zurich, EPFL, and University of Zurich labs, often years ahead of a formal fundraising process.

Mission Possible is raising a CHF 20–40 million debut vehicle with a first close expected in 2025. The fund intends to build a concentrated portfolio of 14 to 18 companies, writing initial tickets of CHF 200,000 to CHF 1 million and reserving capital for follow-on rounds through Series A (per the firm's website).

The firm's stated focus is digital, health, deep tech, space, and impact. It does not list consumer internet, enterprise SaaS outside technical verticals, or financial services among its investment criteria. The portfolio construction appears deliberately narrow around science-driven spin-offs from Swiss technical universities.

The firm operates as a direct investor, leading and participating in equity rounds. There is no public indication of a fund-of-funds allocation or LP commitments to other venture managers. Its sole disclosed investment, Seprify, was a direct seed round led by Mission Possible alongside other VCs, angels, and foundations.